[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338009-105":59,"doc-detail-338009-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","targeting-patient-derived-orthotopic-gastric-cancers-with-a-fluorescent-humanized-anti-cea-antibody","Targeting Patient-Derived Orthotopic Gastric Cancers with a Fluorescent Humanized Anti-CEA Antibody","","Gastric cancer requires accurate surgical staging because resection is the only potential cure, and achieving R0 margins strongly influences survival. Two patient-derived gastric cancer PDOX lines (KG8, KG10) were established and treated with humanized anti-CEA antibody (M5A) or IgG control, each conjugated to IRDye800CW. After 72 hours, LI-COR Pearl fluorescence imaging quantified tumor-to-background ratios (TBR). M5A-IR800 produced bright, specific labeling with markedly higher TBRs than controls, supporting clinical utility for assessing resectability and visualizing margins.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/targeting-patient-derived-orthotopic-gastric-cancers-with-a-fluorescent-humanized-anti-cea-antibody/338009/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/targeting-patient-derived-orthotopic-gastric-cancers-with-a-fluorescent-humanized-anti-cea-antibody/338009.png","ImageObject",300,407,{"name":92,"@type":93},"Oliver","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main objective of targeting gastric tumors in this study?","Question",{"text":112,"@type":113},"To enable specific visualization of gastric cancer in order to distinguish resectable versus nonresectable disease and support achieving R0 resection margins.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were the patient-derived orthotopic xenograft (PDOX) models created?",{"text":117,"@type":113},"Tumor fragments from gastrectomy specimens were implanted into the stomach of mice to establish PDOX models using the KG8 and KG10 gastric cancer lines.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the key results of using the fluorescent humanized anti-CEA antibody?",{"text":121,"@type":113},"M5A-IR800 produced bright, specific fluorescence labeling in both KG8 and KG10 tumors, yielding substantially higher tumor-to-background ratios than the IgG-IR800 control.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},338009,1790165730,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Ann Surg Oncol (2024) 31:6291–6299  \n[https://doi.org/10.1245/s10434-024-15570-9](https://doi.org/10.1245/s10434-024-15570-9)  \nORIGINAL ARTICLE – TRANSLATIONAL RESEARCH  \nTargeting Patient‑Derived Orthotopic Gastric Cancers with a Fluorescent Humanized Anti‑CEA Antibody  \nKristin E. Cox, MD1,2, Michael A. Turner, MD1,2, Thinzar M. Lwin, MD3, Siamak Amirfakhri, PhD1,2, Kaitlyn J. Kelly, MD4, Mojgan Hosseini, MD5, Pradipta Ghosh, MD6,7, Marygorret Obonyo, PhD7, Robert M. Hoffman, PhD1,2,8, Paul J. Yazaki, PhD9, and Michael Bouvet, MD1,2  \n1Department of Surgery, University of California San Diego, La Jolla, CA; 2VA San Diego Healthcare System, San Diego, CA; 3Department of Surgical Oncology, City of Hope National Medical Center, Duarte, CA; 4Department of Surgical Oncology, University of Wisconsin, Madison, WI; 5Department of Pathology, University of California San Diego, La Jolla, CA; 6Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA; 7Department of Medicine, University of California San Diego, La Jolla, CA; 8AntiCancer Inc, San Diego, CA; 9Department of Immunology & Theranostics, Beckman Research Institute of the City of Hope, Duarte, CA  \nABSTRACT  \nBackground. Gastric cancer poses a major diagnostic and therapeutic challenge as surgical resection provides the only opportunity for a cure. Specific labeling of gastric cancer could distinguish resectable and nonresectable disease and facilitate an R0 resection, which could improve survival. Methods. Two patient-derived gastric cancer lines, KG8 and KG10 , were established from surgical specimens of two patients who underwent gastrectomy for gastric adenocarcinoma. Harvested tumor fragments were implanted into the greater curvature of the stomach to establish patientderived orthotopic xenograft (PDOX) models. M5A (humanized anti-CEA antibody) or IgG control antibodies were conjugated with the near-infrared dye IRDye800CW. Mice received 50 µg ofM5A-IR800 or 50 µg of IgG-IR800 intravenously and were imaged after 72 hr. Fluorescence imaging was performed by using the LI-COR Pearl Imaging System. A tumor-to-background ratio (TBR) was calculated by dividing the mean fluorescence intensity of the tumor versus adjacent stomach tissue.  \nMeeting Presentation: Presented at The Society of Surgical Oncology annual meeting in Boston, MA in March 2023.  \n© The Author(s) 2024  \nFirst Received: 2 April 2024  \nAccepted: 21 May 2024  \nPublished online: 18 June 2024  \nM. Bouvet, MD  \n[e-mail: mbouvet@ucsd.edu](e-mail: mbouvet@ucsd.edu)  \nResults. M5A-IR800 administration resulted in bright labeling of both KG8 and K10 tumors. In the KG8 PDOX models, the TBR for M5A-IR800 was 5.85 (SE ± 1.64) compared with IgG-IR800 at 0.70 (SE ± 0.17) . The K10 PDOX models had a TBR of 3.71 (SE ± 0 .73) for M5A-IR800 compared with 0.66 (SE ± 0.12) for IgG-IR800 .  \nConclusions. Humanized anti-CEA (M5A) antibodies conjugated to fluorescent dyes provide bright and specific labeling of gastric cancer PDOX models. This tumor-specific fluorescent antibody is a promising potential clinical tool to detect the extent of disease for the determination of resectability as well as to visualize tumor margins during gastric cancer resection.  \nKeywords Gastric cancer · Patient-derived orthotopic xenograft · PDOX · Fluorescence · Fluorescent antibody · CEA · Tumor targeting · Tumor labeling  \nGastric cancer is the fifth most common cancer diagnosed and is the fourth leading cause of cancer-related deaths worldwide, with the highest rates found in Eastern Asia and Eastern Europe.1 In the United States, gastric cancer is the fifteenth most commonly diagnosed cancer, and recent evidence suggests that the incidence of early-stage gastric cancer is increasing.2,3 Current guidelines by the National Cancer Comprehensive Network (NCCN) and European Society for Medical Oncology (ESMO) recommend resection for localized gastric cancers, with the possibility to perform endoscopic resection fo","cbCaiojWve51Djp9","https://ap.wps.com/l/cbCaiojWve51Djp9","pdf",1338531,"English","# Abstract\n# Background\n# Methods\n## Mouse Models\n# Results\n# Conclusions\n# Keywords","[{\"question\":\"What was the main objective of targeting gastric tumors in this study?\",\"answer\":\"To enable specific visualization of gastric cancer in order to distinguish resectable versus nonresectable disease and support achieving R0 resection margins.\"},{\"question\":\"How were the patient-derived orthotopic xenograft (PDOX) models created?\",\"answer\":\"Tumor fragments from gastrectomy specimens were implanted into the stomach of mice to establish PDOX models using the KG8 and KG10 gastric cancer lines.\"},{\"question\":\"What were the key results of using the fluorescent humanized anti-CEA antibody?\",\"answer\":\"M5A-IR800 produced bright, specific fluorescence labeling in both KG8 and KG10 tumors, yielding substantially higher tumor-to-background ratios than the IgG-IR800 control.\"}]","Targeting Patient-Derived Orthotopic Gastric Cancers with a Fluorescent Humanized Anti-CEA Antibody | PDF",1790021552,23,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eb0003bdaf0eac4f8b57f3a93f8097db.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8fd5dab7aaa53b72762e7276a8943b06.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a8220d5340dbf185814adab759159f67.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5dcd25b4e650f6caac0a742a726fb9b2.webp",980,1301]